Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
Authors: Drilon, A.1 drilona@mskcc.org, Camidge, D. R.2, Lin, J. J.3, Kim, S.-W.4, Solomon, B. J.5, Dziadziuszko, R.6, Besse, B.7, Goto, K.8, de Langen, A. J.9, Wolf, J.10, Lee, K. H.11, Popat, S.12, Springfeld, C.13, Nagasaka, M.14, Felip, E.15, Yang, N.16, Velcheti, V.17, Lu, S.18, Kao, S.19, Dooms, C.20
Source: New England Journal of Medicine. 1/11/2024, Vol. 390 Issue 2, p118-131. 14p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMoa2302299